Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Cells|September 26, 2025
mRNA Multipeptide-HLA Class II Immunotherapy for MelanomaApostolos P Georgopoulos, Lisa M James, Matthew SandersJournal of Immunological Sciences|June 10, 2026
Predicted high affinity binding of prion PRPC protein to Human Leukocyte Antigen (HLA)Apostolos P Georgopoulos, Lisa M James, Matthew SandersCancer Informatics|August 29, 2024
Nine Human Leukocyte Antigen (HLA) Class I Alleles are Omnipotent Against 11 Antigens Expressed in Melanoma TumorsApostolos P Georgopoulos, Lisa M James, Matthew SandersBiology|April 13, 2026
In Silico-Identified Peptides of Five Borrelia burgdorferi Proteins Binding with High Affinity to Human Leukocyte Antigen (HLA) Class II AllelesApostolos P Georgopoulos, Lisa M James, Matthew SandersCancer Informatics|May 30, 2023
Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma TumorsApostolos P Georgopoulos, Lisa M James, Spyros A Charonis, et al.BJC Reports|November 8, 2024
Direct administration of human leucocyte antigen (dHLA) molecules into tumour sites: proposal for a new immunotherapy for cancerApostolos P Georgopoulos, Lisa M JamesBrain, Behavior, & Immunity - Health|December 9, 2022
Immunogenetics of posttraumatic stress disorder (PTSD) in women veteransLisa M James, Apostolos P GeorgopoulosNeuroscience Insights|December 4, 2023
Positive Association Between the Immunogenetic Human Leukocyte Antigen (HLA) Profiles of Multiple Sclerosis and Brain CancerLisa M James, Apostolos P GeorgopoulosJournal of Immunological Sciences|August 4, 2025
Immunogenetic Epidemiology of Type 1 Diabetes in 14 Continental Western European CountriesLisa M James, Apostolos P GeorgopoulosJournal of Immunological Sciences|August 1, 2025
Immunogenetic Epidemiology of Multiple Sclerosis in 14 Continental Western European CountriesLisa M James, Apostolos P GeorgopoulosPageof 23